Gemma Slinn B.Sc (Hons), M.Phil.

Gemma Slinn

Institute of Applied Health Research
Trials Management Team Leader

Contact details

Birmingham Clinical Trials Unit
University of Birmingham
B15 2TT

Gemma is a Trials Management Team Leader at the Birmingham Clinical Trials Unit (BCTU).


  • M.Phil. in Immunology (2008)
  • B.Sc (Hons) in Cell and Molecular Biology (2004)


Gemma holds a bachelor’s degree in cell and molecular biology (first class) and a master’s degree in immunology (host-pathogen interactions in the upper respiratory tract). Prior to working in clinical research, Gemma was a Biomedical Scientist (specialising in microbiology). Gemma has held a number of research and trial management positions both in the NHS and academia and is now a Trials Management Team Leader at Birmingham Clinical Trials Unit (BCTU).  

The diverse portfolio of clinical trials that Gemma manages, comprises research projects in major trauma, burns, critical care, cardiology, hepatology and women’s health.


Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial). Tripathi D, Hayes PC, Richardson P, Rowe I, Ferguson J, Devine P, Mathers J, Poyner C, Jowett S, Handley K, Grant M, Slinn G, Ahmed K, Brocklehurst P. BMJ Open Gastroenterol. 2019 Apr 25;6(1):e000290. doi: 10.1136/bmjgast-2019-000290. eCollection 2019.

Pressure garment to prevent abnormal scarring after burn injury in adults and children: the PEGASUS feasibility RCT and mixed-methods study. Moiemen N, Mathers J, Jones L, Bishop J, Kinghorn P, Monahan M, Calvert M, Slinn G, Gardiner F, Bamford A, Wright S, Litchfield I, Andrews N, Turner K, Grant M, Deeks J. Health Technol Assess. 2018 Jun;22(36):1-162. doi: 10.3310/hta22360.

RePHILL: protocol for a randomised controlled trial of pre-hospital blood product resuscitation for trauma. Smith IM, Crombie N, Bishop JR, McLaughlin A, Naumann DN, Herbert M, Hancox JM, Slinn G, Ives N, Grant M, Perkins GD, Doughty H, Midwinter MJ; RePHILL Trial Collaborators. Transfus Med. 2017 Nov 28. doi: 10.1111/tme.12486.

A randomized, multicenter, open-label, blinded end point trial comparing the effects of spironolactone to chlorthalidone on left ventricular mass in patients with early-stage chronic kidney disease: Rationale and design of the SPIRO-CKD trial. Hayer MK, Edwards NC, Slinn G, Moody WE, Steeds RP, Ferro CJ, Price AM, Andujar C, Dutton M, Webster R, Webb DJ, Semple S, MacIntyre I, Melville V, Wilkinson IB, Hiemstra TF, Wheeler DC, Herrey A, Grant M, Mehta S, Ives N, Townend JN. Am Heart J. 2017 Sep;191:37-46. doi: 10.1016/j.ahj.2017.05.008. Epub 2017 May 24.

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial. Kotecha D, Calvert M, Deeks JJ, Griffith M, Kirchhof P, Lip GY, Mehta S, Slinn G, Stanbury M, Steeds RP, Townend JN. BMJ Open. 2017 Jul 20;7(7):e015099. doi: 10.1136/bmjopen-2016-015099.